Back to Search
Start Over
TCT-330 Multi-Center Evaluation of a Novel 120 μm Novolimus-Eluting, Fully Bioresorbable Coronary Scaffold: First Report of 6-month Imaging and 12-Month Clinical Results
- Source :
- Journal of the American College of Cardiology. 70:B135-B136
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- The DESolve Cx study is a prospective, multi-center evaluation of the safety and efficacy of the DESolve® Cx Novolimus-Eluting Bioresorbable Coronary Scaffold System (BCSS) using clinical endpoints and multiple imaging modalities. The DESolve Cx BCSS is a novel, thin strut (120 μm) drug eluting
- Subjects :
- medicine.medical_specialty
Scaffold
business.industry
05 social sciences
030204 cardiovascular system & hematology
Surgery
Imaging modalities
03 medical and health sciences
0302 clinical medicine
0502 economics and business
Clinical endpoint
medicine
050211 marketing
Cardiology and Cardiovascular Medicine
Nuclear medicine
business
Subjects
Details
- ISSN :
- 07351097
- Volume :
- 70
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Cardiology
- Accession number :
- edsair.doi...........00629ec0b0e369f09faf8b8d37129cd6